Also known as: CDC
The FDA reversed its refusal to review Moderna’s mRNA flu vaccine application and accepted a revised filing with split age cohorts and a post-market study for adults over 65. The reversal came amid broader vaccine regulatory uncertainty and industry concern about unpredictable review timelines.
Congress rejected the administration’s deepest proposed science cuts, increasing NIH funding by about $415 million to $48.7 billion. NASA and NSF also saw far smaller reductions than proposed.
The acting director of the CDC delayed publication of a report showing the COVID-19 vaccine cut emergency department visits and hospitalizations for healthy adults last winter by about half. The Department of Health and Human Services did not immediately respond to request for comment.
VYLOY (zolbetuximab-clzb) remains the only approved CLDN18.2-targeted therapy for first-line HER2-negative gastric or gastroesophageal junction adenocarcinoma with CLDN18.2-positive tumors. The pipeline is focused on next-generation antibodies, ADCs, CAR-T, NK-cell and bispecific approaches aiming to build on zolbetuximab benchmark data.
NVIDIA and Eli Lilly announced a $1 billion AI co-innovation lab as AI drug discovery expands across research, trials and manufacturing. Companies including Recursion and Tempus are using large biological and clinical datasets to speed development and support precision medicine.
The CDC reported six new influenza-associated pediatric deaths in Week 6 of 2026, bringing the 2025-2026 U.S. season total to 71. About 90% of deaths with known vaccination status were in children not fully vaccinated.
NanoViricides has filed regulatory applications for its antiviral candidate NV-387, seeking both Rare Pediatric Disease Drug Designation for measles treatment and Orphan Drug Designation for both measles and MPox treatments. The company could qualify for significant incentives including tax credits, fee exemptions, market exclusivity, and potentially a Priority Review Voucher worth approximately $160 million. There are currently no approved drugs for treating either measles or MPox, with both diseases showing concerning case trends.
Trump administration cuts to U.S. science funding have raised fears of a brain drain, with thousands of grants cancelled and researchers moving abroad. Experts warned the losses could damage biomedical innovation and the economy.
Thousands of research positions have been terminated or frozen at federal agencies following deep cuts to U.S. science funding by the Trump administration, affecting work from aging studies to global food security.
GSK's RSV vaccine Arexvy received expanded FDA approval to cover all high-risk adults, adding approximately 21 million Americans under 50 to the eligible population and matching competitor approvals from Pfizer and Moderna.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07527988 |
Safer Drinking Spaces Study |
NOT_YET_RECRUITING | NA |
| NCT07527871 |
Emergency Department-Substance Use Screening, Motivational Interviewing and Active Referral Targeting Substance Use Disorder and Overdose Prevention |
NOT_YET_RECRUITING | NA |
| NCT07494019 |
Community Safety and Violence |
RECRUITING | |
| NCT07481305 |
Lifestyle Change Implementation Research Network at PRC at UMass Chan |
NOT_YET_RECRUITING | NA |
| NCT07478471 |
Observational Study of Raxibacumab in Sporadic Cases of Systemic Anthrax |
NOT_YET_RECRUITING | |
| NCT07404800 |
Longitudinal Investigation of the Risk and Protective Factors of Dating Violence (Dating it Safe) - Firearms |
ACTIVE_NOT_RECRUITING | |
| NCT07387341 |
Long-acting Spatial Emanators / Repellents (LASER) |
NOT_YET_RECRUITING | NA |
| NCT07368660 |
InPART RX - Epicenters |
COMPLETED | NA |
| NCT07340099 |
Church Implementation of a Social Support Intervention to Increase Physical Activity in Older African American Adults |
NOT_YET_RECRUITING | NA |
| NCT07305467 |
Enhancing an Existing Prevention Strategy to Reduce Intentional Firearm Injuries Among High-risk Youth (Phase 1) |
NOT_YET_RECRUITING | NA |
